Influence of Variations of Systemic Venous Return on Analgesia Nociception Index (ANI) During General Anaesthesia

NCT ID: NCT02193412

Last Updated: 2020-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-04

Study Completion Date

2017-10-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether the value of analgesia nociception index (ANI) is influenced by variations of systemic venous return (cardiac preload) under general anaesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the context of opioid sparing goal during general anaesthesia, the Analgesia nociception index (ANI) is an analgesia/nociception balance monitoring tool computed from high frequency heart rate variability analysis, and developed by MetroDoloris (Lille, France). Its sensitivity to detect noxious stimulus was studied in several studies. However, its specificity is not established in particular in the presence of factors influencing autonomic nervous system other than analgesia/nociception balance. In the context of anaesthesia, one of the most relevant factor is hypovolemia. This study aims to assess the effect of blood volume variations on ANI under general anaesthesia, independently of analgesia/nociception balance status. Variations of systemic venous return (SVR) (cardiac preload), which reflects blood volume status, will be induced by changes of operating table slope, from head-down tilt (Trendelenburg), with increased SVR, to head-up tilt position, with decreased SVR. Variations of SVR will be attested by changes in the arterial pulse pressure variation, a well-established indice of preload responsiveness in the mechanically ventilated anaesthetized patient.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypovolemia Somatic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients

1. noxious stimulus
2. change in operating table slope: head-down tilt position
3. change in operating table slope: head-up tilt position

Group Type EXPERIMENTAL

noxious stimulus

Intervention Type PROCEDURE

standardized noxious stimulus with tetanic stimulation

change in operating table slope: head-down tilt position

Intervention Type PROCEDURE

-30°

change in operating table slope: head-up tilt position

Intervention Type PROCEDURE

+30°

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

noxious stimulus

standardized noxious stimulus with tetanic stimulation

Intervention Type PROCEDURE

change in operating table slope: head-down tilt position

-30°

Intervention Type PROCEDURE

change in operating table slope: head-up tilt position

+30°

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Trendelenburg position

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* neurosurgical operation requiring invasive monitoring of arterial blood pressure

Exclusion Criteria

* pacemaker, arrhythmia
* chronic medication with beta blocker
* possible disorder of autonomic nervous system: diabetes, alcoholism, chronic pain
* anticholinergic drug administration before measures
* intracranial hypertension
* no social security coverage
* pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benoît Tavernier, Pr

Role: PRINCIPAL_INVESTIGATOR

Lille University Hospital

Délégation à la Recherche Clinique et à l'Innovation (DRC)

Role: STUDY_CHAIR

Lille University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital

Lille, Nord, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-A01645-40

Identifier Type: OTHER

Identifier Source: secondary_id

2013_13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.